BMS, Ono partner for prostaglandin receptor antagonist

Ono Pharmaceutical Co. Ltd. (Tokyo:4528) granted Bristol-Myers Squibb Co. (NYSE:BMY) exclusive rights to develop

Read the full 146 word article

User Sign In